Previous 10 | Next 10 |
RANCHO CUCAMONGA, Calif., Nov. 15, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Jason Shandell, President will be presenting at the Jefferies London Healthcare Conference on Thursday, November 21, 2019 at 3:20 p.m. GMT in Aldwych, London, UK. ...
Amphastar Pharmaceuticals, Inc. (AMPH) Q3 2019 Earnings Conference Call November 7, 2019 17:00 ET Company Participants Jason Shandell - President Bill Peters - CFO Conference Call Participants David Amsellem - Piper Jaffray Gary Nachman - BMO Capital Markets David Steinbe...
MannKind ( MNKD ) reported its Q3 earnings last week, and for the most part the company metrics were in line with the projections I have outlined. The company reported revenue of $14.6 million, which included $5.7 million in Afrezza net revenue from the United States and $700,000 in Afrezza ne...
Image source: The Motley Fool. Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) Q3 2019 Earnings Call Nov 7, 2019 , 5:00 p.m. ET Operator Continue reading
Reports Net Revenues of $80.1 Million for the Three Months Ended September 30, 2019 RANCHO CUCAMONGA, Calif., Nov. 07, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) (“Amphastar” or the “Company”) today reported results for the three...
RANCHO CUCAMONGA, Calif., Nov. 01, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the Company will release results for its third quarter of 2019 ended September 30th, 2019, after the market closes on Thursday, November 7th, 2019, and will hold a confe...
Shares of Amphastar ( AMPH ) have performed relatively well since my last check-in over three months ago, up about 19% compared to a gain of 6.6% for the S&P 500. My previous view on the company was overwhelmingly neutral, and in spite of a nearly $60 million settlement with Sandoz ( N...
The following slide deck was published by Amphastar Pharmaceuticals, Inc. in conjunction with this Read more ...
RANCHO CUCAMONGA, Calif., Aug. 29, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Jason Shandell, President, and Bill Peters, CFO, will be presenting at the Wells Fargo 2019 Healthcare Conference on Thursday, September 5, 2019 at 3:05 p.m. Easte...
As many readers know, I have covered the MannKind ( MNKD ) story for quite some time. Over the years I have outlined various projections and models with a particular focus on the cash situation and cash flows at MannKind. Subsequent to the termination of the Sanofi ( SNY ) deal, MannKind fou...
News, Short Squeeze, Breakout and More Instantly...
Amphastar Pharmaceuticals Inc. Company Name:
AMPH Stock Symbol:
NASDAQ Market:
Amphastar Pharmaceuticals Inc. Website:
RANCHO CUCAMONGA, CA / ACCESSWIRE / May 9, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, and Dan Dischner SVP of Corp. Communication, will participate in an Analyst-Moderated fireside chat at the Bank of America Health Care Conference on Wednesday, M...
Reports Net Revenues of $171.8 Million for the Three Months Ended March 31, 2024 RANCHO CUCAMONGA, CA / ACCESSWIRE / May 8, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company") today reported results for the three months ended March 31, 2024. First Quarter ...